stars 1 stars 2 stars 3

Evofem Biosciences, Inc., (OTCID: EVFM) is a San-Diego based pharmaceutical company commercializing two FDA-approved sexual and reproductive health products. In 2020, we launched PHEXX® (lactic acid, citric acid, and potassium bitartrate), the first and only hormone-free, on-demand prescription contraceptive vaginal gel. In 2024, Evofem acquired and re-launched SOLOSEC® (secnidazole) 2 g oral granules, an FDA-approved single-dose oral antibiotic for the treatment of bacterial vaginosis (BV) and trichomoniasis. Visit phexx.com and solosec.com to learn more and for important safety information.

Evofem Biosciences Questions

The Evofem Biosciences annual revenue was $17.7 million in 2026.

Saundra Pelletier is the CEO ► Phexxi ► Solosec of Evofem Biosciences.

35 people are employed at Evofem Biosciences.

Evofem Biosciences is based in San Diego, California.

The NAICS codes for Evofem Biosciences are [32541, 325, 32, 3254].

The SIC codes for Evofem Biosciences are [28, 283].

Top Evofem Biosciences Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users